Combination of the MEK inhibitor pimasertib with BTK or PI3K-delta inhibitors is active in preclinical models of aggressive lymphomas

Title
Combination of the MEK inhibitor pimasertib with BTK or PI3K-delta inhibitors is active in preclinical models of aggressive lymphomas
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 27, Issue 6, Pages 1123-1128
Publisher
Oxford University Press (OUP)
Online
2016-03-10
DOI
10.1093/annonc/mdw131

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started